ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Organ Systems Programs “Filling the Gaps” With Targeted Research

January 23, 1987

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

NCI, Private Groups, Promote Mammograms To Blacks, Hispanics

April 25, 1992

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

House Appropriations Boosts NIH By $1 Billion In Draft Budget That Cuts Other HHS Programs

September 30, 2011

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985